These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 22794806)

  • 21. Reply of the authors.
    Horev A; Haim A; Zvulunov A
    Pediatr Endocrinol Rev; 2015 Sep; 13(1):479. PubMed ID: 26540766
    [No Abstract]   [Full Text] [Related]  

  • 22. Propranolol treatment for infantile hemangioma: a case series of sixty-two patients.
    Stringari G; Barbato G; Zanzucchi M; Marchesi M; Cerasoli G; Tchana B; Gritti A; Boccaletti V; Lombardi AA; Carano N
    Pediatr Med Chir; 2016 Jun; 38(2):113. PubMed ID: 27345601
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Successful management of airway hemangioma with propranolol.
    Mendiratta V; Varghese B; Chander R; Parakh A; Solanki RS
    Int J Dermatol; 2013 Jun; 52(6):750-2. PubMed ID: 23679882
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Propranolol in a case series of 174 patients with complicated infantile haemangioma: indications, safety and future directions.
    Hermans DJ; Bauland CG; Zweegers J; van Beynum IM; van der Vleuten CJ
    Br J Dermatol; 2013 Apr; 168(4):837-43. PubMed ID: 23278381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Response to "Propranolol Induced Hypoglycemia" by Amir Horev, MD, Alon Haim, MD, Alex Zvulunov, MD.
    Theiler M; Drolet BA; Frieden IJ
    Pediatr Endocrinol Rev; 2015 Sep; 13(1):477-8. PubMed ID: 26540765
    [No Abstract]   [Full Text] [Related]  

  • 26. [News on infantile hemangioma therapy by beta-blocker].
    Delmotte N; Curti C; Montana M; Crozet M; Vanelle P; Gensollen S
    Therapie; 2012; 67(3):257-65. PubMed ID: 22874493
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Propranolol for infantile hemangiomas.
    Bagazgoitia L; Torrelo A; Gutiérrez JC; Hernández-Martín A; Luna P; Gutiérrez M; Baño A; Tamariz A; Larralde M; Alvarez R; Pardo N; Baselga E
    Pediatr Dermatol; 2011; 28(2):108-14. PubMed ID: 21385205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Propranolol treatment for severe infantile hemangiomas: a single-centre 3-year experience.
    Georgountzou A; Karavitakis E; Klimentopoulou A; Xaidara A; Kakourou T
    Acta Paediatr; 2012 Oct; 101(10):e469-74. PubMed ID: 22804809
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of β-blockers in dermatological treatment: a review.
    Chen L; Tsai TF
    J Eur Acad Dermatol Venereol; 2018 Mar; 32(3):363-371. PubMed ID: 28850731
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A retrospective study of propranolol therapy in 635 infants with infantile hemangioma.
    Luo Y; Zeng Y; Zhou B; Tang J
    Pediatr Dermatol; 2015; 32(1):151-2. PubMed ID: 24602103
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hemangioma can be effectively treated with propranolol. Experiences from twelve cases, with promising results and few side effects].
    Rosenkvist CJ; Brudin L; Jörgensen E
    Lakartidningen; 2013 May 7-21; 110(19-20):942-5. PubMed ID: 23745499
    [No Abstract]   [Full Text] [Related]  

  • 32. Late rebound of infantile hemangioma after cessation of oral propranolol.
    Shehata N; Powell J; Dubois J; Hatami A; Rousseau E; Ondrejchak S; McCuaig C
    Pediatr Dermatol; 2013; 30(5):587-91. PubMed ID: 24016283
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of propranolol for the treatment infantile hemangiomas in the maxillofacial region.
    Sadykov RR; Podmelle F; Sadykov RA; Kasimova KR; Metellmann HR
    Int J Oral Maxillofac Surg; 2013 Jul; 42(7):863-7. PubMed ID: 23618833
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Propranolol treatment in periocular pediatric patients with hemangiomas.
    Boyce J; Dodge-Palomba S
    Insight; 2010; 35(1):22-3. PubMed ID: 20218265
    [No Abstract]   [Full Text] [Related]  

  • 35. Infantile hemangioma and β-blockers: When, how, and why?
    Navarro-Triviño FJ; Ruíz-Villaverde R; Naranjo-Sintes R
    Actas Dermosifiliogr; 2016 Sep; 107(7):601-2. PubMed ID: 27208910
    [No Abstract]   [Full Text] [Related]  

  • 36. Patient Perspectives: Propranolol for infantile hemangiomas.
    Pediatr Dermatol; 2016 Sep; 33(5):549-50. PubMed ID: 27595871
    [No Abstract]   [Full Text] [Related]  

  • 37. Propranolol for recalcitrant ulcerated hemangioma of infancy.
    Hong E; Fischer G
    Pediatr Dermatol; 2012; 29(1):64-7. PubMed ID: 21854419
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A further experience of propranolol for severe infantile hemangiomas of the face: an observational study.
    Greco A; D'Erme AM; Zamma Gallarati B; Caputo R; de Martino M
    Dermatol Ther; 2014; 27(4):198-202. PubMed ID: 24548454
    [TBL] [Abstract][Full Text] [Related]  

  • 39. β-blockers for infantile hemangiomas: a single-institution experience.
    Blatt J; Morrell DS; Buck S; Zdanski C; Gold S; Stavas J; Powell C; Burkhart CN
    Clin Pediatr (Phila); 2011 Aug; 50(8):757-63. PubMed ID: 21525081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety profile of a divided dose of propranolol for heart rate in children with infantile haemangioma during 16 weeks of treatment.
    Song H; Shi H; Zhang X; Wang J; Yu Y; Chen W; Zhou H
    Br J Dermatol; 2015 Feb; 172(2):444-9. PubMed ID: 25041341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.